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Differential response of glomerular epithelial and mesangial cells after
subtotal nephrectomy. Recent studies in both human and experimental
chronic renal disease suggest that there is a linkage between glomerular
hypertrophy and glomerulosclerosis. To further define these relationships,
we studied the changes in glomerular hypertrophy, procollagen a1(IV)
mRNA levels and glomerulosclerosis in rats undergoing 12⁄3 nephrectomy
(Nx) or sham nephrectomy (SNx). Glomerular hypertrophy, measured
biochemically by RNA/DNA and protein/DNA ratios, was significantly
increased in Nx compared to SNx two days after subtotal renal ablation
(RNA/DNA: Nx 5 133 6 8%, SNx 5 100 6 3% of the mean control value,
P , 0.01; protein/DNA: Nx 5 164 6 22%, SNx 5 100 6 10%, P , 0.05)
and remained elevated after 7 and 15 days (RNA/DNA: seven days Nx 5
155 6 3%, SNx 5 100 6 13%, P , 0.01; 15 days Nx 5 303 6 21%, SNx 5
100 6 24%, P , 0.001; protein/DNA: seven days Nx 5 228 6 57%, SNx 5
100 6 18%, P , 0.05; 15 days Nx 5 341 6 23%, SNx 5 100 6 18%, P ,
0.01). Light microscopic measures of glomerular tuft volume (GTV) were
too insensitive to detect glomerular enlargement until 15 days postoper-
atively, but GTV measured ultrastructurally demonstrated a 20% incre-
ment in Nx compared to SNx as early as two days postoperatively (P ,
0.01). The latter increment in GTV was due exclusively to glomerular
visceral epithelial cell (GVEC) expansion. Glomerular procollagen
a1(IV) mRNA levels were significantly elevated only 15 days after
nephrectomy (Nx 5 265 6 58% of the mean control value, SNx 5 100 6
12%, P , 0.05; corrected for b-actin mRNA levels). At this time,
exuberant mesangial expansion measured ultrastructurally contributed to
a 1.6 6 0.1-fold increase in GTV (P , 1025), and to a relative decrement
in the GVEC contribution to glomerular cells plus matrix (P , 0.01).
Segmental sclerosis was observed only 15 days postoperatively in Nx (Nx 5
1.3 6 0.4% of glomeruli evaluated, SNx 5 0.0%, P , 0.05), and there was
a strong correlation between the prevalence of segmental sclerosis and the
procollagen a1(IV) mRNA levels in Nx at 15 days (r 5 0.93, P , 0.01).
There was no significant correlation between the RNA/DNA and protein/
DNA ratios and procollagen a1(IV) mRNA levels. Thus, glomerular
regions responded differentially to subtotal nephrectomy. Early epithelial
cell expansion was followed by later mesangial expansion. Glomerular
procollagen a1(IV) mRNA levels were elevated only during the second
(mesangial) phase of glomerular hypertrophy, when it correlated with
glomerulosclerosis, but not during the initial (epithelial) phase, a pattern
consistent with a mesangial origin of the procollagen a1(IV) mRNA.
Glomerular hypertrophy is observed in both human [1–6] and
experimental [7–10] forms of renal disease that progress to
end-stage renal failure. In recent years there has been increasing
evidence suggesting that glomerular hypertrophy is linked to the
subsequent development of glomerulosclerosis [11, 12]. Various
pathogenetic mechanisms have been proposed to explain how
glomerular hypertrophy can lead to sclerosis. These include the
acceleration of hypertensive glomerular injury [11], increased
glomerular tension possibly leading to mesangial stretch [13, 14],
changes in the glomerular capillary wall leading to diminished
capillary hydraulic conductivity (Lp) [15], and injury to glomerular
epithelial cells leading to a state of so-called “relative epithelial
cell deficiency” [16, 17]. It has further been proposed that the
close linkage between glomerular hypertrophy and glomeruloscle-
rosis may be the consequence of secretion of growth-promoting
factors released as part of an adaptive response to a reduction in
nephron mass [18–20]. Under these conditions, growth-promot-
ing factors have exocrine and autocrine effects on glomerular cells
that stimulate hypertrophy, proliferation and extracellular matrix
formation. These responses ultimately prove to be maladaptive as
excessive matrix obliterates the glomerular capillary lumen giving
rise to typical sclerotic lesions. Hence, glomerular hypertrophy
and hyperplasia are often present in close association with the
development of glomerulosclerosis [12, 18–20].
Type IV collagen is an important component of the glomerular
basement membrane and mesangial matrix under physiological
conditions [21, 22]. Although the exact composition of the mate-
rial in glomerulosclerotic lesions remains a matter of controversy,
and in fact may vary among the different glomerular disorders,
several studies demonstrate the presence of Type IV collagen as
a major component, along with other molecules of the extracel-
lular matrix including laminin, fibronectin, tenascin, and Types I
and III collagen [23–30]. The studies described herein were
performed in order to more clearly define the temporal relation-
ships between hypertrophy of the distinct glomerular compart-
ments (such as mesangium, endothelium, visceral epithelial cells,
parietal epithelial cells, capillary lumen, and urinary space), the
expression of increased steady-state levels of glomerular procol-
lagen a1(IV) mRNA levels and the development of segmental
sclerosis. In these experiments, we used the 12⁄3 nephrectomy
model, characterized pathologically by an early increase in glo-
merular size, accumulation of extracellular matrix material, and
progressive focal and segmental glomerulosclerosis [31–34]. Our
previous work and the work of others has demonstrated that this
model is characterized by an increase in classical Type IV collagen
both at the mRNA [31] and the protein [27] levels.
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METHODS
Surgical procedure
Male Sprague-Dawley rats were subjected to 12⁄3 nephrectomy
(Nx) by the performance of a right nephrectomy and ligation of
two-thirds to three-quarters of the arterial supply to the left
kidney. Control animals underwent a sham procedure (SNx) that
consisted of a laparotomy and manipulation of the renal pedicles
without damage to the renal tissue. The rats were anesthetized
with ketamine 87 mg/kg body wt and xylazine 13 mg/kg body wt.
Rats were pair-fed beginning on the second postoperative day. To
study the pathogenetic and temporal relationships between pro-
collagen a1(IV) [PCa1(IV)] mRNA levels, glomerular hypertro-
phy, and glomerulosclerosis, rats were sacrificed 2 (SNx, N 5 7;
Nx, N 5 8), 7 (SNx, N 5 7; Nx, N 5 5) and 15 (SNx, N 5 6; Nx,
N 5 6) days after nephrectomy.
Physiological measurements
Physiological measurements were made prior to surgery and
just before sacrifice. The measurements obtained were: body wt,
hematocrit, systolic arterial blood pressure by the tail cuff method
in the awake restrained rat [35], 24-hour urinary protein by
sulfosalicylic acid precipitation and turbidometric analysis [36]
and serum creatinine using a Beckman autoanalyzer (Beckman
Industries, Irvine, CA, USA). Animals were fed standard rat chow
and pair feeding began two days after surgery. The animals were
sacrificed under general anesthesia 2, 7 and 15 days after nephrec-
tomy. Wet left kidney weights, inclusive of the infarcted areas,
were obtained at sacrifice. The infarcted areas were manually
separated from the hypertrophied tissue and discarded prior to
glomerular isolation.
In vitro hybridization
Glomeruli were isolated from the remaining cortical tissue by
differential sieving using mesh diameters of 75, 105 and 125
microns [37]. The glomerular samples, which averaged 93% pure
and were a minimum of . 85% pure, were snap-frozen in liquid
nitrogen. Total RNA was isolated either by the guanidinium
thiocyanate (GT) phenol chloroform extraction method [38] or
with RNAzol B (Cinna/Biotecx Laboratories, Friendswood, TX,
USA) [39].
Total RNA was quantitated spectrophotometrically by optical
density readings at 260 nm. Samples were included in the final
analysis if (1) 260/280 nm optical density ratios were between 1.7
and 2.2; (2) a sufficient amount of RNA was present for slot blot
quantitation; and (3) the correlation coefficient for the slot blot
autoradiogram linear regression was $ 0.85 when analyzing a
minimum of three serial dilutions. Due to the small quantity of
total RNA, the presence of intact 28S and 18S RNA bands on
ultraviolet transillumination of the ethidium bromide stained
formaldehyde agarose gels were assessed only in representative
glomerular samples.
Slot blot quantitation was performed by blotting five serial
dilutions of total RNA from each animal on nitrocellulose filters
(Nitroplus 2000; Micron Separations, Inc., Westboro, MA, USA).
The filters were vacuum baked at 80°C, pre-hybridized and
subsequently hybridized overnight with specific 32P radiolabeled
cDNA probes for PCa1(IV) or b-actin. Characteristics of probes
are detailed below. Hybridized filters were washed to a stringency
of 0.1 3 SSC (with 0.1% SDS for b-actin) at 37°C and developed
with Kodak XAR film with two Quanta III intensifying screens
(Kodak, Rochester, NY, USA) at 270°C. Developed autoradio-
graphs were quantitated using a laser densitometer (Helena
Laboratories, Beaumont, TX, USA). Specific mRNA levels were
measured as optical density units per microgram of total RNA as
calculated based on linear regression for each experimental
animal. The mRNA levels of each experimental animal were
subsequently expressed as the percentage of the mean value
obtained in the control rats.
In the rats sacrificed at two days, little hypertrophy was present,
and RNA from separate rats was pooled for analysis. However, all
measurements in the 7 and 15 day experiments were performed in
individual animals, and these data were utilized to examine
correlative relationships.
Northern analysis
To confirm the slot-blot results, an additional 27 rats were
operated upon and sacrificed 2 (SNx, N 5 4; Nx, N 5 8), 7 (SNx,
N 5 2; Nx, N 5 4) and 15 (SNx, N 5 2; Nx, N 5 7) days after
surgery for the performance of Northern hybridization studies for
PCaI(IV) and b-actin. Northern analysis was performed as pre-
viously described [40, 41] and quantitated by laser densitometry.
Unlike the data in the slot-blot experiments in which data points
at 7 and 15 days were unique for each individual rat and therefore
could be used for correlations with morphometric measurements,
in the Northern analysis experiments, glomerular RNA from
nephrectomized rats were pooled in order to collect 10 mg of total
RNA per lane. The following cDNA probes were utilized: (1)
mouse procollagen a1(IV) cDNA pPE123 [42]; and (2) rat b-actin
cDNA LK #280 [43]. Northern analysis demonstrated binding to
mRNA bands of 6.8 and 5.9 Kb for pPE123 and to a 2.1 Kb
mRNA for LK #280 [40, 41].
Renal histology and morphometric analysis
Thin coronal sections were fixed in alcoholic Bouin’s solution,
transferred to 70% ethanol after 24 hours, embedded in paraffin,
sectioned and stained with periodic acid-Schiff reagent. Only
areas distant from the infarcted tissue were evaluated.
The glomeruli were examined for the presence of mesangial
expansion, increase in mesangial cells beyond three in each
mesangial area and protein reabsorption droplets and vacuoliza-
tion of the glomerular visceral epithelial cells. In each rat, an
individual feature was quantified as the number of glomeruli in
which the feature was present divided by the total number of
glomeruli examined multiplied by one hundred (%). Segmental
sclerosis was defined as a constellation of abnormalities including
hyalinosis, glomerular visceral epithelial cell vacuolization and/or
proliferation resulting in capillary collapse with or without seg-
mental mesangial expansion. Mesangial matrix expansion only
referred to increased amounts of extracellular material widening
the mesangial areas. Segmental sclerosis was quantified in percent
as described above.
Light microscopy was utilized to measure the glomerular sur-
face area and to calculate the glomerular tuft volume from the
measured surface area. Glomerular surface area was measured in
a minimum of 100 glomeruli from each experimental animal using
a Zeiss light microscope and digitizer tablet. Glomerular tuft
volume (GTV) by light microscopy was calculated by the formula
(Equation 1):
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GTVLM 5 1.25 ~Glomerular surface area!3/2 @1,44#. (Eq. 1)
Use of this formula presumes the glomerulus to be spherical, an
assumption which may overestimate glomerular volume. The
GTVLM was expressed as a percentage of the control mean value.
Biochemical and ultrastructural measure of glomerular
hypertrophy and glomerular volume
To measure glomerular hypertrophy by more sensitive bio-
chemical and ultrastructural measures than could be achieved by
the light microscopic morphometric assessments afforded by
computerized planimetry, separate animals were raised and sac-
rificed 2 (SNx, N 5 4, Nx, N 5 12), 7 (SNx, N 5 7, Nx, N 5 5) and
15 (SNx, N 5 5, Nx, N 5 13) days after nephrectomy.
Biochemical measures of hypertrophy
Hypertrophy was assessed by comparing glomerular RNA/
DNA and protein/DNA ratios in Nx compared with SNx [45, 46].
Glomerular total RNA was quantitated by the methods described
above, glomerular protein content by the Lowry assay [47] and
DNA by bisbenzimide spectroflourimetry [48]. Glomerular sam-
ples in the nephrectomized rats sacrificed 2 and 15 days after
nephrectomy were pooled for the biochemical measurements.
Ultrastructural measures of glomerular volume
Ultrastructural morphometry was performed utilizing standard
stereological techniques [49–51]. Portions of renal cortex from
animals sacrificed 2 and 15 days after Nx or SNx were fixed in
2.5% glutaraldehyde, processed in the routine manner and em-
bedded in Epon. Methylene blue stained one micron sections
were serially cut and examined by light microscopy until a
glomerulus entered the section. Glomeruli identified in this
manner then had one thin section cut for ultrastructural exami-
nation, followed by 2 micron sections for light microscopy. This
pattern was repeated until the glomeruli were completely sec-
tioned through from top to bottom. All thin sections were
examined using a JEOL 100B electron microscope and the
glomeruli photographed in their entirety at 80003 magnification.
Additionally, 11 random cross sections from central portions of
other glomeruli from independent Nx and SNx animals were
photographed at 80003 magnification.
The photographs were subjected to point counting by superim-
posing a grid over the photo montages and identifying the
glomerular region under the area where the grid lines intersected
at a point, as described by Mauer et al and utilized by Hayashi et
al [49, 50]. The following regions were quantified by this analysis:
glomerular basement membranes (GBM); glomerular parietal
epithelial cells (GPEC); urinary space; glomerular visceral epithe-
lial cells (GVEC); mesangium (including mesangial cells, nuclei
and matrix as a single region); endothelial cells; capillary lumens;
and grid (area obscured by electron microscopy grid). Fractional
volumes were calculated by dividing the total number of points
per glomerulus for a given region, by the total number (N) of
glomerular points counted, and multiplying by 100. For example,
the fractional glomerular visceral epithelial cell volume (VVGVEC)
was calculated as follows in Equation [2]:
VVGVEC 5
~GVEC points per glomerulus!
~total N glomerular tuft points!
3 100 (Eq. 2)
Fractional volumes for the mesangium, capillary lumens, base-
ment membrane, and urinary space were calculated similarly. In
addition, the GVEC volume was also expressed as a fraction
relative to the cellular and extracellular material of the glomerular
tuft (GVEC/GTV-lumen). It was calculated by substituting the
denominator in Equation (2) above with the expression (total N
glomerular tuft points 2 N capillary lumen points), where N is
number, mathematically described as Equation (3):
GVEC
GTV-lumen
5
~GVEC points per glomerulus!
~total N glomerular tuft points!
~total N capillary lumen points!
2 (Eq. 3)
For Nx, 20,149 points were assessed in the 2 and 15 day
specimens. For SNx, due to the smaller overall size of the
glomeruli, 14,368 points were assessed. Percent results from the
eleven random glomerular sections of Nx and SNx rats were no
different from those obtained from the serially sectioned glomer-
uli, as reported by MacLeod et al [51]. Only the results of the
serially sectioned glomeruli are therefore reported.
Statistics
All values are expressed as mean 6 standard error of the mean
(SEM). The Student’s t-test was used to assess differences between
groups and significance was assigned at the P , 0.05 level.
RESULTS
Experimental animals
Body weights, serum creatinines, 24-hour urinary protein excre-
tion, hematocrits and systolic arterial blood pressures were not
significantly different when Nx was compared to SNx in measure-
ments made prior to surgery in the 2, 7 and 15 day experiments.
Physiological parameters in Nx and SNx just prior to sacrifice are
summarized in Table 1.
It should be noted that in the initial two days, Nx rats
experienced a greater weight loss than SNx (P , 0.001), but once
pair feeding began at day 2 the differences in body wt were
minimized such that the final body wts in the two groups were not
statistically significant 7 or 15 days after nephrectomy. Wet left
kidney weights were significantly elevated by two days after
nephrectomy in Nx when compared to SNx (P , 0.001) and
remained elevated at 7 (P , 0.05) and 15 (P , 0.05) days. When
factored for body wt, the differences in wet left kidney weights
between Nx and SNx became even more pronounced.
In vitro hybridization studies
Mean glomerular PCa1(IV) mRNA levels were not signifi-
cantly different in the two groups 2 (SNx 5 100 6 5, Nx 5 59 6
13% mean control value) and 7 (SNx 5 100 6 11, Nx 5 123 6
26%) days after nephrectomy. In fact, at two days the glomerular
procollagen a1(IV) mRNA levels in Nx were numerically lower
than in SNx, whether expressed uncorrected or after correction
for control b-actin mRNA levels. However, at 15 days after
nephrectomy, the glomerular PCa1(IV) mRNA levels were sig-
nificantly elevated in Nx (240 6 39%, P , 0.05) when compared
with SNx (100 6 9%). There was no statistically significant change
in b-actin mRNA levels between the two groups at the three time
intervals studied (2 days: SNx 5 100 6 13, Nx 5 79 6 17; 7 days:
SNx 5 100 6 8, Nx 5 94 6 21; 15 days: SNx 5 100 6 7, Nx 5 95 6
8%). When PCa1(IV) levels were corrected for the level of
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control b-actin mRNA to account for loading differences and/or
non-specific changes in mRNA levels, the same results were
noted. Thus, the procollagen a1(IV)/b-actin mRNA ratio was
increased only in the animals who were nephrectomized 15 days
before (P , 0.05 vs. SNx) and no increase was noted at the earlier
time intervals (Fig. 1).
Northern analysis
The Northern analysis utilized glomeruli pooled from several
animals in the Nx group in order to electrophorese 10 mg of total
RNA per lane. The results confirmed the slot blot quantitations in
that the PCa1(IV) mRNA levels in Nx were higher than SNx only
at 15 days (Fig. 2A), but not 2 or 7 days postoperatively. This
result was unchanged whether PCa1(IV) mRNA levels were
calculated uncorrected, or as corrected for control b-actin
mRNA. The corrected values showed no change in Nx compared
to SNx at 2 (SNx 5 100, Nx 5 127 6 14% of control mean) or 7
(SNx 5 100, Nx 5 90 6 10%) days after nephrectomy. There was
a twofold increase in the ratio 15 days after nephrectomy in Nx
(SNx 5 100, Nx 5 200%). Due to the small number of samples
analyzed, these data were not subjected to statistical analysis, and
groups with only two lanes (N 5 2) are expressed as an average
value without the standard error of the mean. Ethidium bromide
staining of the electrophoresed samples demonstrated equal
loading of RNA in paired samples at 2, 7 and 15 days (Fig. 2B).
Renal histology and light microscopic morphometric analysis
Renal tissue was examined in areas distant from the infarcted
regions and there was no difference in histology for the parame-
ters evaluated between Nx and SNx 2 and 7 days postoperatively.
No segmental sclerosis was observed in the sections from the
nephrectomized rats at 2 or 7 days (Figs. 3 A–C). However, 15
days after nephrectomy, glomeruli from Nx rats exhibited signif-
icantly more mesangial expansion (Nx 5 1.73 6 0.6%, SNx 5
0.05 6 0.03%, P , 0.05) and more segmental sclerosis (Nx 5
1.3 6 0.4%, SNx 5 0.0%, P , 0.05) than SNx (Fig. 3D). Visceral
epithelial cell vacuolization and the presence of protein reabsorp-
tion droplets in glomerular epithelial cells were more commonly
noted in the glomeruli of Nx rats than SNx, but these findings
were not statistically significant.
There were no significant differences in the glomerular tuft
volumes measured by light microscopic computerized planimetry
2 (SNx 5 100 6 0.3, Nx 5 108 6 4.6) and 7 (SNx 5 100 6 13.6,
Nx 5 119 6 18.4) days after nephrectomy when Nx was compared
to SNx. However, by 15 days postoperatively, Nx had larger
glomerular tuft volumes than SNx (SNx 5 100 6 2, Nx 5 168 6
5%, P , 0.01) (Figs. 3 A, D).
There was a strong correlation between glomerular procollagen
a1(IV) mRNA levels and segmental sclerosis (r 5 0.93, P , 0.01;
Fig. 4) in Nx 15 days after nephrectomy. There was no correlation
between PCa1(IV) mRNA levels and glomerular tuft volume in
Nx at 7 or 15 days.
Biochemical measurements of glomerular hypertrophy
RNA/DNA and protein/DNA ratios, 2, 7 and 15 days after
nephrectomy are shown in Figures 5 A and B, respectively. Both
the RNA/DNA and protein/DNA ratios were significantly ele-
vated in Nx two days post-nephrectomy and the differences
became even more pronounced at 7 and 15 days when compared
to SNx. Thus, biochemical measures suggest glomerular enlarge-
ment as early as two days after nephrectomy, while computerized
planimetry performed by light microscopy could not detect glo-
merular enlargement until the fifteenth postoperative day.
Fig. 1. Glomerular procollagen a1(IV)/b-actin mRNA levels 2, 7 and 15
days after surgery. The ratios were significantly elevated in Nx (f)
compared to SNx (M) only 15 days after nephrectomy (*P , 0.05).
Table 1. Physiological parameters in SNx and Nx rats just prior to sacrifice 2, 7 and 15 days after nephrectomy
Group
BW LKW LKW/BW 3 100 Cr BP Hct UP Food Intake
g % mg/dl mmHg % mg/24h g/day/100gBW
2 day
SNx 209 6 2 0.9 6 0.03 0.4 6 0.02 0.2 6 0.02 ND 44 6 1.6 6.0 6 2.5 7.1 6 0.5
Nx 185 6 3a 1.2 6 0.04a 0.7 6 0.02a 0.8 6 0.05a ND 44 6 2.2 6.5 6 0.07 6.8 6 0.3
7 day
SNx 203 6 6 0.9 6 0.03 0.4 6 0.02 0.3 6 0.04 128 6 1 46 6 0.8 5.5 6 0.0 7.2 6 0.5
Nx 187 6 9 1.2 6 0.10c 0.7 6 0.04b 0.7 6 0.02a 176 6 1a 49 6 1.6 12.9 6 0.4 6.7 6 0.3
15 day
SNx 203 6 6 0.8 6 0.04 0.4 6 0.01 0.2 6 0.02 135 6 5 48 6 1.3 2.1 6 0.4 17.0 6 1.2
Nx 202 6 12 1.2 6 0.11c 0.6 6 0.04b 0.9 6 0.07a 210 6 8a 44 6 1.2 14.6 6 4.2c 16.0 6 1.4
Data are mean 6 SEM.
a P , 0.001, b P , 0.01, c P , 0.05 vs. SNx
Abbreviations are: BW, body weight; LKW, left kidney weight; LKW/BW, left kidney weight to body weight ratio; Cr, serum creatinine; BP, systolic
blood pressure; Hct, hematocrit; UP, 24-hour urinary protein excretion; ND, not done.
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Correlative data were available only for the 7 day animals and
no significant correlation between the biochemical measures of
hypertrophy and procollagen a1(IV) mRNA levels was noted.
Ultrastructural measures of glomerular volume
Due to the discrepancies between light microscopic computer-
ized planimetry measures of GTV and biochemical measures of
glomerular hypertrophy at 2 and 7 days postoperatively, the % of
each glomerular region contributing to the overall glomerular
volume was quantified by electron microscopy. This provided a
more sensitive measure of glomerular enlargement than what can
be achieved at the light microscopic level. In addition, it allowed
for a quantitative description of regional glomerular expansion
over time. Electron microscopic morphometry confirmed the
biochemical measurement of hypertrophy in that statistically
significant glomerular enlargement was present on the second
postoperative day (Fig. 6). On day 2, GTV measured by electron
microscopy in Nx rats and corrected for SNx (Nx/SNx) was 1.2 6
0.1 (P , 0.01). A regional analysis of this enlargement revealed
that it was ascribable exclusively to expansion of the glomerular
visceral epithelial cells (GVEC) without any significant changes in
other glomerular compartments, including the mesangium, glo-
merular basement membrane, endothelium, or capillary lumens.
Fractional GVEC volume in Nx at two days was 43 6 1%,
compared to 36 6 1% in SNx (P , 0.001; Table 2). Thus, the
fractional GVEC volume (GVEC/GTV 5 VvGVEC) in Nx/SNx
was 1.2 6 0.4 (P , 0.05). On an absolute scale, GVEC expansion
in Nx/SNx was 1.5 6 0.1 (P , 0.01). The GVEC/GTV-lumen in
Nx/SNx was 1.2 6 0.1 (P , 0.01; Fig. 6). Glomerular parietal
epithelial cells (GPEC) also increased in volume by 44% at this
time (P , 0.05) compared to SNx. The increase in GVEC and
GPEC was accompanied by a compensatory 22% decrement in
the volume of the urinary space in Nx relative to SNx (P , 0.05).
Fifteen days postoperatively, there was further glomerular
enlargement. The GTV increased in Nx/SNx to 1.6 6 0.1 (P ,
1025). However, the involved glomerular regions comprising this
enlargement had changed, reflecting small relative contributions
by GVECs, a larger mesangial contribution, and a compensatory
decrease in the fractional capillary lumenal volume. Relative
GVEC enlargement in Nx was maximal at two days without
further enlargement compared to SNx 15 days postoperatively.
Fractional GVEC volume had fallen in Nx to from 43 6 1% at two
days to 38 6 4% at 15 days (Table 2). Thus, the absolute ratio of
GVEC in Nx/SNx at both the two days and the 15 days time points
were 1.5 6 0.1 (P , 0.01). However, the relative proportion of the
combined cellular and matrix components of the glomerulus
represented by GVEC (GVEC/GTV-lumen) had declined in
Nx/SNx on day 15 to 0.88 6 0.03% (P , 0.01; Fig. 6). This change
was due to a simultaneous large increment in the mesangial
volume and a corresponding decrease in the fractional volume of
the capillary lumen (Nx 26 6 3%, SNx 32 6 4%, P , 0.0002). The
mesangium expanded dramatically with Nx/SNx increasing on an
absolute scale 2.6 6 0.1-fold (P , 1026). At 15 days, while the
fractional mesangial volume (Vvmes) was 17 6 5% in SNx, in the
Nx rats it was 28 6 5% (P , 0.001; Table 2). Thus, by the fifteenth
postoperative day, mesangial enlargement and not GVEC expan-
sion contributed more overall to the increase in GTV.
DISCUSSION
Glomerular hypertrophy is characteristic of many forms of
chronic renal disease [1–10] and has been implicated in the
pathogenesis of glomerulosclerosis [11–13, 15–25, 31–35, 51].
Previous studies from our lab and others demonstrated that after
subtotal nephrectomy, Type IV collagen and procollagen a1(IV)
mRNA levels are increased in hypertrophied and sclerosing
glomeruli [27, 31]. Our current studies were performed in order to
establish the temporal relationships between glomerular hyper-
trophy, procollagen a1(IV) mRNA levels, and glomerulosclerosis.
These studies demonstrated that glomerular hypertrophy, as
evidenced by increased RNA/DNA and protein/DNA ratios and
confirmed by electron microscopic morphometry, was present as
early as two days postoperatively in nephrectomized rats. In this
initial phase of early hypertrophy, occurring two days postopera-
tively, glomerular enlargement was comprised exclusively of
Fig. 2. A. Representative Northern hybridization of pooled RNA samples
(10 mg per lane) from the sham nephrectomy (SNx) group and from rats
15 days after nephrectomy (Nx). Nx procollagen a1(IV) mRNA levels
were elevated approximately twofold at 15 days compared to SNx. (B)
Ethidium bromide staining of samples from A, demonstrating 18S and 28S
ribosomal bands of equal intensity, confirming equivalent loading of RNA
among paired samples.
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GVEC expansion. In a second later phase of hypertrophy, occur-
ring at 15 days, glomerular hypertrophy was comprised predom-
inantly of mesangial enlargement, with a continuing but stable
contribution by hypertrophied GVEC. Overall, due to the exu-
berance of the mesangial response in the later phase of glomer-
ular hypertrophy, there was a relative decline in the GVEC
contribution to glomerular mass (GVEC/GTV-lumen). Thus, our
data demonstrate that after subtotal nephrectomy, hypertrophy of
the glomerular tuft proceeds in two distinct phases. The first
phase is comprised uniquely of GVEC expansion. In the second
phase, fractional GVEC volume declines. In this latter phase, the
GVEC contribution is diminished by mesangial expansion, which
becomes the predominant contributor to glomerular hypertrophy.
Procollagen a1(IV) mRNA levels were significantly elevated in
the nephrectomized rats only in the late phase and not during the
early phase of glomerular hypertrophy. Furthermore, no segmen-
tal sclerosis was observed in the nephrectomized rats during the
early phase of hypertrophy at 2 or 7 days postoperatively, and only
a small percentage of glomeruli were segmentally sclerosed in the
Fig. 3. Representative sections from renal cortex of rats 2, 7 and 15 days after surgery. A. Control rat at two days. B. Nx rat two days after nephrectomy.
C. Nx rat at seven days after nephrectomy. In A, B, and C there are no changes in the glomeruli and no segmental sclerosis. D. Nx rat 15 days after
nephrectomy. There is an area of segmental sclerosis (arrow) in the hypertrophied glomerulus (Periodic-acid Schiff 3250).
Fig. 4. Correlation between glomerular procollagen a1 (IV) mRNA levels
and percent of glomeruli with segments of sclerosis in the nephrectomy
(Nx) group 15 days after surgery. There was a strong correlation between
the prevalence of segmental sclerosis and the procollagen a1(IV) mRNA
levels in Nx, r 5 0.93, P , 0.01).
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nephrectomized rats at 15 days. There was a strong correlation
between the prevalence of segmental sclerosis and the procolla-
gen a1(IV) mRNA levels in the nephrectomized rats 15 days after
surgery. However, there was no correlation between the RNA/
DNA and protein/DNA ratios and the procollagen a1(IV) mRNA
levels at 7 days (the only time point at which correlative data were
available). Therefore the data additionally suggest that procolla-
gen a1(IV) mRNA levels are more closely linked to mesangial
expansion and the development of sclerosis than to glomerular
hypertrophy per se.
While the work of numerous investigators links the develop-
ment of glomerular hypertrophy to the development of glomeru-
losclerosis, the individual regional cellular responses contributing
to hypertrophy have not been well characterized. GVECs are
highly differentiated cells that rarely, if ever, undergo mitosis in
the adult kidney under physiological conditions [52]. Glomerular
hypertrophy has thus been characterized as a pathological state of
relative GVEC deficiency due to the inability of these terminal
cells to divide [52]. Our studies demonstrated early increased
GVEC volume in response to subtotal nephrectomy, a finding also
reported by others [53, 54]. However, ours is the first study to
distinguish an early phase of increased fractional GVEC volume
followed by a later phase of diminished GVEC contribution, the
latter phase the likely counterpart of the proposed state of GVEC
“deficiency.”
The contribution of GVEC hypertrophy to the subsequent
development of glomerulosclerosis is one of some controversy.
Most studies support the hypothesis described above, linking
podocyte hypertrophy and injury to glomerulosclerosis. In a
model of glomerulosclerosis due to aging, Floege et al described
glomerular hypertrophy and podocyte injury preceding sclerotic
change in Milan normotensive rats [55]. Similarly, in a model of
glomerulosclerosis in Munich-Wistar rats due to uninephrectomy
and desoxycorticosterone trimethylacetate administration, glo-
merular hypertrophy was accompanied by the presence of de-
nuded basement membranes. This led the authors to conclude
that podocyte failure was a predominant mechanism leading to
glomerulosclerosis in this model [56]. In contrast, despite early
increased podocyte volume after subtotal nephrectomy, negative
correlations between albuminuria and glomerular hypertrophy led
Tenschert, Elger and Lemley [54] to conclude that hypertrophy
may actually ameliorate glomerular injury in its early stages.
While our experiments do not provide definitive data to resolve
this controversy, they nevertheless suggest that during the very
earliest stages of glomerular hypertrophy, an increase in fractional
Fig. 5. Glomerular RNA/DNA ratios (A) and protein/DNA ratios (B) 2, 7
and 15 days after nephrectomy (Nx) or sham (SNx) procedure. The ratios
are significantly higher in Nx compared to SNx at all time intervals studied
(*P , 0.01, **P , 0.001, ***P , 0.05). Symbols are: (M) SNx; (f) Nx.
Fig. 6. Changes in glomerular regions after nephrectomy (Nx). Super-
scripts denote changes in Nx compared to sham nephrectomy (SNx) at the
2 (M) and 15 (f) day time points. Abbreviations are: GTV, glomerular
tuft volume; GVEC, glomerular visceral epithelial cells; Mes is mesan-
gium; A is GVEC/GTV, fractional glomerular visceral epithelial cell
volume; B is GVEC/GTV-lumen, proportion of non-capillary lumen
glomerular tuft comprised of GVEC. *P , 0.05; **P , 0.01; ***P , 1025.
Table 2. Fractional glomerular visceral epithelial and mesangial
volumes
2 day 15 day
%
VVGVEC
Nx 43 6 1a 38 6 4b
SNx 36 6 1 40 6 7
VVMES
Nx 19 6 2b 28 6 5a
SNx 21 6 3 17 6 5
Fractional glomerular visceral epithelial cell volume (VVGVEC); Frac-
tional mesangial volume (VVMES).
a P , 0.001; b P . 0.05; Nx vs. SNx
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GVEC volume is unaccompanied by an increase in classical Type
IV collagen mRNA or glomerulosclerosis, thus potentially repre-
senting a phase of balance. However, a later phase of declining
fractional GVEC volume, accompanied by an increase in glomer-
ular classical Type IV collagen mRNA and evolving glomerulo-
sclerosis, may indeed reflect, at least in part, injury due to a state
of GVEC deficiency.
Our observation that the first phase of glomerular hypertrophy
precedes a rise in glomerular procollagen a1(IV) mRNA levels
could conceivably be method-dependent. However, our temporal
findings are in keeping with other published reports, both with
regard to the timing of the hypertrophy and the timing of the
mRNA increment. The biochemical measures we used were
sensitive means for detecting glomerular hypertrophy. In fact,
these measures were more sensitive for detecting hypertrophy
than the frequently used measurements of light microscopic
computerized planimetry for calculating glomerular tuft volumes.
Renal hypertrophy has classically been defined by increases in
RNA/DNA, protein/DNA or protein/cell ratios [45, 46, 57].
Following unilateral nephrectomy the RNA content of the con-
tralateral kidney has been reported to rise leading to increments
in the RNA/DNA ratio by 12 hours [53, 54]. Protein/cell ratio and
kidney weight increase within the next 12 to 48 hours and by 48
hours the renal RNA/DNA ratio is increased by 20 to 30%, a level
at which it remains for the next few weeks [58–60]. Thus, our
finding of glomerular hypertrophy as early as two days after
subtotal nephrectomy is consistent with earlier reports examining
temporal sequences in the development of renal hypertrophy. The
discrepancy between the biochemical and light microscopic eval-
uations in this study, however, was clarified by the performance of
morphometry at the ultrastructural level. The latter studies re-
vealed that hypertrophy at two days postoperatively was entirely
due to GVEC expansion. Since GVEC borders are often poorly
discerned by light microscopy, it becomes readily apparent why
only the ultrastructural but not the light microscopic morphome-
try was capable of detecting increased GTV at the earliest of the
three time points we studied.
Our data are also consistent with other published works as they
relate to the timing of the increment in glomerular procollagen
a1(IV) mRNA levels. Our data show that increases in glomerular
procollagen a1(IV) mRNA lagged behind the initial phase of
glomerular enlargement by as much as two weeks. Numerical, but
statistically insignificant increments in glomerular procollagen
a1(IV) mRNA levels were present at 7 days, but significant
elevations were not noted until 15 days postoperatively in the
nephrectomized group. These findings were identical whether
assessed by slot-blot in vitro hybridization or by Northern analysis.
Floege et al reported that increments in glomerular procollagen
a1(IV) mRNA levels measured by Northern analysis did not
occur until six weeks after subtotal renal ablation [27]. The
discrepancy in timing between our study and that of Floege et al
may relate to differences in the degree of infarction achieved after
arterial ligation of the remnant kidney resulting in differences in
the severity of the underlying lesion. Alternatively, in the latter
study, glomerular procollagen a1(IV) mRNA levels were mea-
sured at two weeks, and again at six weeks, with no interim
measurements. At two weeks, a numerical but not significant
increase in glomerular procollagen a1(IV) mRNA levels was
noted. Since no additional measurements were obtained between
weeks 2 and 6, it remains possible that the increment in mRNA
levels may actually occur substantially earlier than at six weeks, as
noted in our experiments. In any case, the data do not suggest that
glomerular procollagen a1(IV) mRNA levels increase earlier than
two weeks postoperatively. Finally, Lee, Lovett and Pollock [61]
published preliminary work further supporting two weeks as the
time before which glomerular procollagen a1(IV) mRNA levels
do not increase. In these studies, utilizing a sensitive in situ reverse
transcriptase method for quantitating glomerular procollagen
a1(IV) mRNA levels, Lee et al also found increments in procol-
lagen a1(IV) mRNA levels occurring at two weeks following 12⁄3
nephrectomy [60]. Thus, in three studies examining procollagen
a1(IV) mRNA levels after subtotal renal ablation utilizing three
different techniques (slot-blot, Northern analysis and reverse
transcriptase in situ hybridization), none reported increments in
mRNA earlier than two weeks after surgery. Taken together,
these data make it unlikely that methodological artifact is respon-
sible for the observation that early glomerular hypertrophy pre-
cedes an increment in procollagen a1(IV) mRNA levels after
substantial reduction in renal mass.
Type IV collagen has repeatedly been shown to be an impor-
tant, though not exclusive component of glomerulosclerotic le-
sions [23–25]. The relative contributions of increased matrix
synthesis and decreased degradation in the expanding mesangial
matrix in developing glomerulosclerosis remain poorly defined.
As collagen synthesis is at least in part transcriptionally regulated,
our data demonstrating a twofold increment in mRNA (and the
data of others) suggests a role for increased synthesis in this
process. However, the delay in this increment such that it corre-
lates poorly with glomerular hypertrophy and occurs after hyper-
trophy is well established defies a teleologic notion that an
increase in matrix synthesis must accompany early glomerular
enlargement. The current study does not rule out the possibilities
that classical Type IV collagen accretion during this period might
result from improved translational efficiency or decreased degra-
dation. However, it clearly demonstrates that early glomerular
hypertrophy proceeds in the absence of an increase in steady state
mRNA levels for classical Type IV collagen. The most likely
explanation for this divergence between hypertrophy and the
increase in procollagen a1(IV) mRNA levels is the identification
of heterogeneity in the glomerular response to hypertrophy.
These studies demonstrate that the hypertrophic response of
visceral and parietal epithelial cells in the glomerulus follows a
time course similar to that observed in tubular epithelial cells,
such that measurable hypertrophy is present in both as early as
two days after subtotal nephrectomy. The presence of glomerular
epithelial cell hypertrophy without increased procollagen a1(IV)
mRNA is consistent with the observation that glomerular visceral
epithelial cells synthesize novel but not classical Type IV collagen
[62]. The subsequent development of mesangial expansion in the
later phase of glomerular hypertrophy, accompanied by an incre-
ment in glomerular procollagen a1(IV) mRNA levels, is also
consistent with a mesangial origin of the mRNA.
To summarize, our studies demonstrate two distinct temporal
phases and discrete regional compartmentalization in the glomer-
ular hypertrophic response to renal ablation. An initial early
phase is characterized exclusively by glomerular visceral and
parietal epithelial cell hypertrophy that is unaccompanied by a
significant rise in glomerular procollagen a1(IV) mRNA levels. A
later phase is characterized by exuberant mesangial expansion,
resulting in a relative decline in the fractional glomerular visceral
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epithelial cell volume and an increment in glomerular procollagen
a1(IV) mRNA levels. The lag time between the initial hypertro-
phy of glomerular epithelial cells and the subsequent expansion of
the glomerular mesangium with its attendant increase in procol-
lagen a1(IV) mRNA levels and the development of sclerosis may
thus represent a window during which novel therapeutic interven-
tions may be targeted in order to maintain the adaptive advan-
tages of hypertrophy without incurring glomerulosclerosis.
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APPENDIX
Abbreviations used in this article are: GBM, glomerular basement
membrane; GPEC, glomerular parietal eipthelial cells; GT, guanidinium
thiocyanate; GTV, glomerular tuft volume; GVEC, glomerular visceral
epithelial cells; mes is mesangium; GVEC/GTV, fractional glomerular
visceral epithelial cell volume; GVEC/GTV lumen, proportion of non-
capillary lumen glomerular tuft comprised of GVEC; Nx, 12⁄3 nephrec-
tomy; PCa1(IV), procollagen a1(IV); SNx, sham nephrectomy.
REFERENCES
1. BILOUS RW, MAUER JM, BASGEN JM, STEFFES MW: Estimation of
mean glomerular volume in patients with insulin-dependent diabetes
mellitus. Kidney Int 32:930–932, 1987
2. CASTELLINO P, SHOHAT J, DEFRONZO RA: Hyperfiltration and dia-
betic nephropathy: Is it the beginning? Or is it the end? Semin Nephrol
10:228–241, 1990
3. FOGO A, HAWKINS EP, BERRY PL, GLICK AD, CHIANG ML, MAC-
DONELL RC JR, ICHIKAWA I: Glomerular hypertrophy in minimal
change disease predicts subsequent progression to focal glomerular
sclerosis. Kidney Int 38:115–123, 1990
4. BHATHENA DB, SONDHEIMER JH: The glomerulopathy of homozygous
sickle haemoglobin (SS) disease: Morphology and pathogenesis. J Am
Soc Nephrol 1:1241–1252, 1991
5. OSTERBY R, GUNDERSEN HJG: Glomerular size and structure in
diabetes mellitus. I. Early abnormalities. Diabetologia 11:225–229,
1975
6. GUNDERSEN HJG, OSTERBY R: Glomerular size and structure in
diabetes mellitus. II. Late abnormalities. Diabetologia 13:43–48, 1977
7. OLIVETTI G, ANVERSA P, RIGMONTI W, VITALI-MAZZA L, LOUD AV:
Morphometry of the renal corpuscle during normal postnatal growth
and compensatory hypertrophy. J Cell Biol 75:573–580, 1977
8. SHEA SM, RASKOVA J, MORRSION AB: A stereologic study of glomer-
ular hypertrophy in the subtotally nephrectomized rat. Am J Pathol
90:201–210, 1978
9. PACZEK L, TESCHNER M, SCHAEFER RM, KOVAR J, ROMEN W,
HEDLAND A: Intraglomerular proteinase activity in adriamycin-in-
duced nephropathy. Nephron 60:81–86, 1992
10. SHIMAMURA T: Prevention of 11-deoxycorticosterone-salt-induced
glomerular hypertrophy and glomerulosclerosis by dietary phosphate
binder. Am J Pathol 136:549–556, 1990
11. MILLER PL, RENNKE HG, MEYER TW: Glomerular hypertrophy
accelerates hypertensive glomerular injury in rats. Am J Physiol
261:F459–F465, 1991
12. FOGO A, ICHIKAWA I: Evidence for a pathogenic linkage between
glomerular hypertrophy and sclerosis. Am J Kidney Dis 17:666–669,
1991
13. DANIELS BS, HOSTETTER TH: Adverse effects of growth in the
glomerular microcirculation. Am J Physiol 258:F1409–F1416, 1990
14. HEILIG CW, CONCEPCION LA, RISER BL, FREYTAG SO, ZHU M,
CORTES P: Overexpression of glucose transporters in rat mesangial
cells cultured in a normal glucose milieu mimics the diabetic pheno-
type. J Clin Invest 96:1802–1814, 1995
15. SAVIN VJ, SEATON RD, RICHARDSON WP, DUNCAN KA, BEASON-
GRIFFIN C, AHNEMANN J: Dietary protein and glomerular response to
subtotal nephrectomy in the rat. J Lab Clin Med 113:41–49, 1989
16. FRIES JW, SANDSTORM DJ, MEYER TW, RENNKE HG: Glomerular
hypertrophy and epithelial cell injury modulate progressive glomeru-
losclerosis in the rat. Lab Invest 60:205–218, 1989
17. MILLER PL, SCHOLEY JW, RENNKE HG, MEYER TW: Glomerular
hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin
Invest 85:1119–1126, 1990
18. FOGO A, ICHIKAWA I: Evidence for the central role of growth
promoters in the development of sclerosis. Semin Nephrol 9:329–342,
1989
19. ICHIKAWA I, IKOMA M, FOGO A: Glomerular growth promoters, the
common key mediator for progressive sclerosis in chronic renal
diseases. Adv Nephrol 20:127–148, 1991
20. DOI T, STRIKER LJ, GIBSON CC, AGODOA LY, BRINSTER RL, STRIKER
GE: Glomerular lesions in mice transgenic for growth hormone and
insulin-like growth factor-I. Relationship between increased glomer-
ular size and mesangial sclerosis. Am J Pathol 137:541–552, 1990
21. ABRAHAMSON DR: Structure and development of the glomerular
capillary wall and basement membrane. Am J Physiol 253:F783–F794,
1987
22. COURTOY PJ, TIMPL R, FARQUHAR MG: Comparative distribution of
laminin, type IV collagen, and fibronectin in the rat glomerulus.
J Histochem Cytochem 30:874–886, 1982
23. ABRASS CK, PETERSON CV, RAUGI GJ: Phenotypic expression of
collagen types in mesangial matrix of diabetic and non-diabetic rats.
Diabetes 37:1695–1702, 1988
24. STRIKER LM-M, KILLEN PD, CHI E, STRIKER GE: The composition of
glomerulosclerosis. I. Studies in focal sclerosis, crescenteric glomeru-
lonephritis and membranoproliferative glomerulonephritis. Lab Invest
51:181–192, 1984
25. FALK RJ, SCHEINMAN JI, MAUER SM, MICHAEL AF: Polyantigenic
expansion of basement membrane constituents in diabetic nephropa-
thy. Diabetes 32(Suppl 2):34–39, 1983
26. YANG CW, HATTORI M, VLASSARA H, HE CJ, CAROME MA, YAMOTO
E, ELLIOT S, STRIKER GE, STRIKER LJ: Overexpression of transform-
ing growth factor-beta 1 mRNA is associated with up-regulation of
glomerular tenascin and laminin gene expression in nonobese diabetic
mice. J Am Soc Nephrol 5:1610–1617, 1995
27. FLOEGE J, ALPERS CE, BURNS MW, PRITZL P, GORDON K, COUSER
WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumula-
tion, and the development of glomerulosclerosis in the remnant
kidney model. Lab Invest 66:485–497, 1992
28. NEHRLICH A, SCHLEICHER E: Immunohistochemical localization of
various components of the basal membrane and interstitial collagen in
diabetic nephropathy. Verhandl Deutsch Ges Pathol 73:133–138, 1989
29. GLICK AD, JACOBSON HR, HARALSON MA: Mesangial deposition of
type 1 collagen in human glomerulosclerosis. Human Pathol 23:1373–
1379, 1992
30. KOPP JB, KLOTMAN ME, ADLER SH, BRUGGEMAN LA, DICKIE P,
MARINOS NJ, ECKHAUS M, BRYANT JL, NOTKINS AL, KLOTMAN PE:
Progressive glomerulosclerosis and enhanced renal accumulation of
basement membrane components in mice transgenic for human
immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA
89:1577–1581, 1992
31. LOMBET JR, ADLER SG, ANDERSON PS, NAST CC, OLSEN DR,
GLASSOCK RJ: Sex vulnerability in the subtotal nephrectomy model of
glomerulosclerosis in the rat. J Lab Clin Med 114:66–74, 1989
32. PURKERSON ML, HOFFSTEN PE, KLAHR S: Pathogenesis of the glo-
merulopathy associated with renal infarction in rats. Kidney Int
9:407–417, 1976
33. OLSON JL, HOSTETTER TH, RENNKE HG, BRENNER BM, VENKAT-
ACHALAM MA: Mechanisms of altered glomerular permselectivity and
progressive sclerosis following extreme ablation of renal mass. Kidney
Int 22:112–116, 1982
34. SHIMAMURA T, MORRISON AB: A progressive glomerulosclerosis
occurring in partial five-sixths nephrectomized rats. Am J Pathol
79:95–106, 1975
35. PFEFFER JM, PFEFFER MA, FROEHLICH ED: Validity of an indirect tail
cuff method for determining systolic arterial blood pressure in the
Lee et al: Hypertrophy and procollagen a1(IV) mRNA levels 1397
unanesthetized normotensive and spontaneously hypertensive rats.
J Lab Clin Med 78:957–962, 1971
36. HENRY RJ, CANON DC, WINKELMAN JW: Clinical Chemistry. Principles
and Techniques. New York, Harper and Rowe, 1974
37. SPIRO R: Studies on the renal glomerular basement membrane.
Preparations and chemical composition. J Biol Chem 242:1915–1922,
1967
38. SAMBROOK J, FRITSCH EF, MANIATIS T: Molecular Cloning - A
Laboratory Manual (2nd ed). Cold Spring Harbor, Cold Spring Harbor
Laboratory Publications, 1989
39. CHOMCZYNSKI P, SACCHI N: Single step method of RNA isolation by
acid guanidinium thiocyanate-phenol-guanidinium chloroform extrac-
tion. Anal Biochem 162:156–159, 1987
40. NAST CC, ADLER SG, ARTISHEVSKY A, KRESSER CT, AHMED K,
ANDERSON PS: Cyclosporine induces elevated procollagen a1(I)
mRNA in the rat renal cortex. Kidney Int 39:631–638, 1991
41. IHM CG, LEE GSL, NAST CC, ARTISHEVSKY A, GUILLERMO R, LEVIN
PS, GLASSOCK RJ, ADLER SG: Early increased renal procollagen
a1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int
41:768–777, 1992
42. KURKINEN M, CONDOM MR, BLUMBERG B, BARLOW DP, QUINONES S,
SAUS J, PIHLAJANIEMI T: Extensive homology between the carboxy-
terminal peptides of mouse a1(IV and a2(IV) collagen. J Biol Chem
262:8496–8499, 1987
43. NUDEL V, ZAKUT R, SHANI M, NEUMAN S, LEVY Z, YAFFE D: The
nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic
Acids Res 11:1759–1177, 1983
44. BEUKERS JJB, VANDER WAAL A, HOEDEMAEKER PJ, WEENIG JJ:
Converting enzyme inhibition and progressive glomerulosclerosis in
the rat. Kidney Int 32:794–802, 1987
45. JOHNSON HA, ROMAN JVM: Compensatory renal enlargement. Hy-
pertrophy vs hyperplasia. Am J Pathol 49:1–13, 1966
46. HALLIBURTON IW, THOMSON RY: Chemical aspects of compensatory
renal hypertrophy. Cancer Res 25:1882–87, 1965
47. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein
measurement with the folin phenol reagent. J Biol Chem 193:265–275,
1951
48. LABARCA C, PAIGEN K: A simple, rapid and sensitive DNA assay
procedure. Analyt Biochem 102:344–352, 1980
49. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN
DM, GOETZ FC: Structural-functional relationships in diabetic ne-
phropathy. J Clin Invest 74:1143–1155, 1984
50. HAYASHI H, KARASAWA R, INN H, SAITOU T, UENO M, NISHI S,
SUZUKI Y, OGINO S, MARUYAMA Y, KOUDA Y, ARAKAWA M: An
electron microscopic study of glomeruli in Japanese patients with
non-insulin dependent diabetes mellitus. Kidney Int 41:749–757, 1992
51. MACLEOD JM, WHITE KE, TATE H, BILOUS RW, on behalf of the
European Study of the Progression of Renal Disease in Type 1
(Insulin Dependent) Diabetes (ESPRIT) Study Group. Efficient
morphometric analysis of glomerular mesangium in insulin-dependent
diabetic patients with early nephropathy. Kidney Int 51:1624–1628,
1997
52. RENNKE HG: How does glomerular epithelial cell injury contribute to
progressive glomerular damage? Kidney Int 45(Suppl 45): S58–S63,
1994
53. AMMAN K, NICHOLS C, TORNIG J, SCHWARZ U, ZEIER M, MALL G,
RITZ E: Effect of ramipril, nifedipine, and moxonidine on glomerular
morphology and podocyte structure in experimental renal failure.
Nephrol Dial Transplant 11:1003–1011, 1996
54. TENSCHERT S, ELGER M, LEMLEY KV: Glomerular hypertrophy after
subtotal nephrectomy: Relationship to early glomerular injury. Vir-
chows Arch 426:509–517, 1995
55. FLOEGE J, HACKMANN B, KLIEM V, KRIZ W, ALPERS CE, JOHNSON RJ,
KUHN KW, KOCH KM, BRUNCKHORST R: Age-related glomeruloscle-
rosis and interstitial fibrosis in Milan normotensive rats: A podocyte
disease. Kidney Int 51:230–243, 1997
56. KRETZLER M, KOEPPEN-HAGEMANN I, KRIZ W: Podocyte damage is a
critical step in the development of glomerulosclerosis in the unine-
phrectomised-desoxycorticocosterone hypertensive rat. Virchows Arch
425:181–193, 1994
57. FINE LG: The biology of renal hypertrophy. Kidney Int 29:619–634,
1986
58. JELINEK J, VESELA H, VALOVA: The effects of nortestosterone phe-
nylpronate on compensatory hypertrophy of the remaining kidney
after unilateral nephrectomy. Acta Endocrinol 46:352–359, 1964
59. MALT RA: Compensatory growth of the kidney. N Engl J Med
280:1446–1454, 1969
60. HALLIBURTON IW: The effect of unilateral nephrectomy and of diet on
the composition of the kidney, in Compensatory Renal Hypertrophy,
edited by NOWINSKI WW, GOSS RJ, New York, Academic Press, 1969,
pp 101–128
61. LEE GSL, LOVETT DH, POLLOCK AS: In situ reverse transcriptase:
High level resolution of glomerular matrix protein gene expression.
(abstract) J Am Soc Nephrol 2:578, 1991
62. BUTKOWSKI RJ, WIESLANDER J, KLEPPEL M, MICHAEL AF, FISH AJ:
Basement membrane collagen in the kidney: Regional localization of
novel chains related to collagen IV. Kidney Int 35:1195–1202, 1989
Lee et al: Hypertrophy and procollagen a1(IV) mRNA levels1398
